About Enhancer
| Enhancer ID: | E_01530 |
| Species: | Homo sapiens |
| Position : | chr9:36980000-37150820   |
| Year: | 2023 |
| Title: | Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression |
| Genome Build: | hg38 |
| Enhancer Type: | Super-enhancer |
| Condition: | Disease |
| Disease Name: | diffuse large B-cell lymphoma |
| PMID: | 38049665 |
| MONDO: | MONDO:0005042 |
| Tissue: | Lymph node |
| Tissue Ontology ID: | UBERON:0000029 |
| Cell Source: | SUDHL10 |
| CVCL ID: | CVCL_1744 |
| Cell Type: | diffuse large B-cell lymphoma cell |
| Cell Ontology ID: | CL:0000945 |
| Experiment Type: | Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq, Hi-C, 4C-seq |
| Low Throughput Method: | CRISPR Knockout, qRT-PCR, FISH |
About Target Gene
| Target gene : | PAX5 |
About TF
| TF name : |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Expression of Target Genes for the Enhancer